QIAGEN NV's ticker is QGEN and the CUSIP is N72482123. A total of 271 filers reported holding QIAGEN NV in Q4 2020. The put-call ratio across all filers is 0.22 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,073,250 | -10.1% | 26,500 | 0.0% | 0.01% | 0.0% |
| Q2 2023 | $1,193,295 | -2.0% | 26,500 | 0.0% | 0.01% | 0.0% |
| Q1 2023 | $1,217,145 | -7.9% | 26,500 | 0.0% | 0.01% | -10.0% |
| Q4 2022 | $1,321,555 | +20.8% | 26,500 | 0.0% | 0.01% | +11.1% |
| Q3 2022 | $1,094,000 | -12.5% | 26,500 | 0.0% | 0.01% | -10.0% |
| Q2 2022 | $1,251,000 | -3.7% | 26,500 | 0.0% | 0.01% | +11.1% |
| Q1 2022 | $1,299,000 | -11.8% | 26,500 | 0.0% | 0.01% | 0.0% |
| Q4 2021 | $1,473,000 | +5.6% | 26,500 | -1.9% | 0.01% | 0.0% |
| Q3 2021 | $1,395,000 | +6.8% | 27,000 | 0.0% | 0.01% | +12.5% |
| Q2 2021 | $1,306,000 | -1.4% | 27,000 | -0.7% | 0.01% | -11.1% |
| Q1 2021 | $1,324,000 | -34.4% | 27,200 | -28.8% | 0.01% | -35.7% |
| Q4 2020 | $2,019,000 | -36.7% | 38,200 | -37.4% | 0.01% | -44.0% |
| Q3 2020 | $3,188,000 | -10.8% | 61,000 | -26.9% | 0.02% | -13.8% |
| Q2 2020 | $3,575,000 | +10.0% | 83,500 | +6.9% | 0.03% | 0.0% |
| Q1 2020 | $3,249,000 | – | 78,100 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Varenne Capital Partners | 607,000 | $24,588,839 | 23.75% |
| SYCOMORE ASSET MANAGEMENT | 428,513 | $16,866 | 4.32% |
| Nekton Capital Ltd. | 614,940 | $24,905,070 | 3.95% |
| Grandeur Peak Global Advisors, LLC | 847,699 | $34,331,810 | 2.58% |
| Southpoint Capital Advisors LP | 1,500,000 | $60,750,000 | 1.36% |
| Point72 Europe (London) LLP | 468,364 | $18,968,742 | 1.16% |
| SECTOR GAMMA AS | 100,713 | $4,078,877 | 1.04% |
| Susquehanna International Securities, Ltd. | 28,711 | $1,162,796 | 0.98% |
| Bank of Italy | 651,125 | $26,399 | 0.84% |
| PDT Partners, LLC | 123,216 | $4,990,248 | 0.63% |